Rallybio CorporationRLYBNASDAQ
LOADING
|||
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
263.64%
↑ 3166% above average
Average (22q)
8.07%
Historical baseline
Range
High:263.64%
Low:-46.87%
Volatility
3846.3%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 263.64% |
| Q2 2025 | -4.76% |
| Q1 2025 | 16.00% |
| Q4 2024 | 3.85% |
| Q3 2024 | 29.73% |
| Q2 2024 | 21.28% |
| Q1 2024 | 6.00% |
| Q4 2023 | -11.11% |
| Q3 2023 | 2.17% |
| Q2 2023 | -6.98% |
| Q1 2023 | 6.52% |
| Q4 2022 | 23.33% |
| Q3 2022 | -5.26% |
| Q2 2022 | -18.75% |
| Q1 2022 | -14.29% |
| Q4 2021 | -13.51% |
| Q3 2021 | -2.78% |
| Q2 2021 | 40.00% |
| Q1 2021 | -27.66% |
| Q4 2020 | -46.87% |
| Q3 2020 | -45.45% |
| Q2 2020 | -29.41% |
| Q1 2020 | 0.00% |